Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$13.84
+0.4%		$12.43
$6.26
▼
$15.89
$1.16B0.63815,222 shs445,694 shs
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$5.18
+1.4%		$4.29
$2.20
▼
$5.78
$307.14M0.5312,497 shs154,456 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$20.83
+1.1%		$20.32
$16.67
▼
$42.43
$1.18B0.891.58 million shs687,244 shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$22.11
-1.3%		$25.66
$15.59
▼
$35.87
$1.12B1.26980,246 shs442,976 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
+0.36%-3.76%+5.49%+62.63%+84.78%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
+1.37%-3.36%+36.32%+32.48%+82.39%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
+1.12%-3.92%+16.50%-20.89%-48.95%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-1.25%-4.45%-7.37%-26.03%-19.63%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioventus Inc. stock logo
BVS
Bioventus
$13.84
+0.4%		$12.43
$6.26
▼
$15.89
$1.16B0.63815,222 shs445,694 shs
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$5.18
+1.4%		$4.29
$2.20
▼
$5.78
$307.14M0.5312,497 shs154,456 shs
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$20.83
+1.1%		$20.32
$16.67
▼
$42.43
$1.18B0.891.58 million shs687,244 shs
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$22.11
-1.3%		$25.66
$15.59
▼
$35.87
$1.12B1.26980,246 shs442,976 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioventus Inc. stock logo
BVS
Bioventus
+0.36%-3.76%+5.49%+62.63%+84.78%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
+1.37%-3.36%+36.32%+32.48%+82.39%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
+1.12%-3.92%+16.50%-20.89%-48.95%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-1.25%-4.45%-7.37%-26.03%-19.63%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioventus Inc. stock logo
BVS
Bioventus
2.83
Moderate Buy$16.8021.39% Upside
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
2.71
Moderate Buy$13.00150.97% Upside
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
2.19
Hold$28.0034.42% Upside
STAAR Surgical Company stock logo
STAA
STAAR Surgical
2.08
Hold$28.4028.45% Upside

Current Analyst Ratings Breakdown

Latest OBIO, PRCT, BVS, and STAA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/17/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$28.00
8/17/2026
Bioventus Inc. stock logo
BVS
Bioventus
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$15.00 ➝ $19.00
8/17/2026
Bioventus Inc. stock logo
BVS
Bioventus
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$15.00
8/17/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetHold$31.00 ➝ $28.00
8/13/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold$28.00
8/13/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D-) ➝ Sell (D+)
8/13/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
William Blair logo
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$33.00
8/13/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
8/13/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
UBS Group AG logo
UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetSell$20.00 ➝ $19.00
8/13/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
Wedbush logo
Wedbush
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOutperform$40.00 ➝ $37.00
8/11/2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
Piper Sandler logo
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$9.00 ➝ $10.00
(Data available from 8/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioventus Inc. stock logo
BVS
Bioventus
$581.85M2.00$1.28 per share10.81$3.30 per share4.19
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
$33.48M9.30N/AN/A$0.32 per share16.19
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
$308.05M3.87N/AN/A$5.94 per share3.51
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$239.44M4.63N/AN/A$7.29 per share3.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioventus Inc. stock logo
BVS
Bioventus
$22.73M$0.7717.9715.551.769.36%28.08%9.82%N/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$52.70M-$0.85N/AN/AN/A-184.60%-149.61%-54.15%11/9/2026 (Estimated)
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$95.57M-$1.94N/AN/AN/A-32.53%-30.62%-22.10%11/3/2026 (Estimated)
STAAR Surgical Company stock logo
STAA
STAAR Surgical
-$80.45M$0.07315.9040.94N/A1.13%9.05%6.99%11/4/2026 (Estimated)

Latest OBIO, PRCT, BVS, and STAA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$0.2214$0.39+$0.1686$0.39$90.60 million$93.54 million
8/10/2026Q2 2026
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
-$0.3920-$0.38+$0.0120-$0.38$0.14 million$0.09 million
8/5/2026Q2 2026
Bioventus Inc. stock logo
BVS
Bioventus
$0.22$0.22N/A$0.47N/A$153.21 million
8/4/2026Q2 2026
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
-$0.4619-$0.47-$0.0081-$0.47$92.77 million$94.50 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bioventus Inc. stock logo
BVS
Bioventus
N/AN/AN/AN/AN/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioventus Inc. stock logo
BVS
Bioventus
0.83
1.69
1.17
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
1.80
8.26
8.24
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
0.15
6.55
5.35
STAAR Surgical Company stock logo
STAA
STAAR Surgical
N/A
4.66
4.03

Institutional Ownership

CompanyInstitutional Ownership
Bioventus Inc. stock logo
BVS
Bioventus
62.94%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
53.20%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
89.46%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
96.70%

Insider Ownership

CompanyInsider Ownership
Bioventus Inc. stock logo
BVS
Bioventus
33.50%
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
7.50%
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
4.00%
STAAR Surgical Company stock logo
STAA
STAAR Surgical
39.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bioventus Inc. stock logo
BVS
Bioventus
1,20084.09 million55.92 millionN/A
Orchestra BioMed Holdings, Inc. stock logo
OBIO
Orchestra BioMed
460.10 million55.60 millionNot Optionable
PROCEPT BioRobotics Corporation stock logo
PRCT
PROCEPT BioRobotics
43057.27 million54.98 millionOptionable
STAAR Surgical Company stock logo
STAA
STAAR Surgical
1,21150.14 million30.14 millionOptionable

Recent News About These Companies

STAAR Surgical Company (NASDAQ:STAA) Receives Average Rating of "Hold" from Brokerages
August 29 at 2:28 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30989736
STAAR Surgical Company (NASDAQ:STAA) Receives Consensus Rating of "Hold" from Brokerages
August 29 at 2:28 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-staar-surgical-company-nasdaq-staa-receives-consensus-rating-of-hold-from-brokerages-2026-08-29/
Staar Surgical Targets Presbyopia Growth With New Trifocal ICL Trial
August 27 at 12:50 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/staar-surgical-targets-presbyopia-growth-with-new-trifocal-icl-trial?utm_source=marketbeat.com&utm_medium=referral
Staar Surgical Advances Next‑Gen ICL Study, Signaling Long‑Term Growth Potential
August 27 at 12:50 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/staar-surgical-advances-nextgen-icl-study-signaling-longterm-growth-potential?utm_source=marketbeat.com&utm_medium=referral
American Capital Management Inc. Makes New $24.29 Million Investment in STAAR Surgical Company $STAA
August 27 at 3:23 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-american-capital-management-inc-makes-new-2429-million-investment-in-staar-surgical-company-staa-2026-08-27/
5 insightful analyst questions from STAAR Surgical’s Q2 earnings call
August 20, 2026  |  msn.comhttps://www.msn.com/en-us/money/other/5-insightful-analyst-questions-from-staar-surgical-s-q2-earnings-call/ar-AA2asi4b
STAAR Surgical (NASDAQ:STAA) Trading Down 6.6% After Analyst Downgrade
August 19, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30969221
Stifel Nicolaus Has Lowered Expectations for STAAR Surgical (NASDAQ:STAA) Stock Price
August 19, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30969030
Why STAAR Surgical (STAA) shares are sliding today
August 17, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/why-staar-surgical-staa-shares-are-sliding-today/ar-AA2ajyu1
Why STAAR Surgical (STAA) Is Up 8.1% After Q2 Profit Rebound And New CEO Appointment
August 17, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/why-staar-surgical-staa-8-190804380.html
STAAR Surgical (NASDAQ:STAA) Shares Down 6.6% Following Analyst Downgrade
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/staar-surgical-nasdaqstaa-shares-down-66-following-analyst-downgrade-2026-08-17/
Deciphering Staar Surgical (STAA) International Revenue Trends
August 17, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2975548/deciphering-staar-surgical-staa-international-revenue-trends?cid=cs-stocknewsapi-ft-fundamental_analysis|nfm_international_revenues-2975548
Stifel Nicolaus Lowers STAAR Surgical (NASDAQ:STAA) Price Target to $28.00
August 17, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/stifel-nicolaus-lowers-staar-surgical-nasdaqstaa-price-target-to-2800-2026-08-17/
Quantinno Capital Management LP Takes $1.11 Million Position in STAAR Surgical Company $STAA
August 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-quantinno-capital-management-lp-takes-111-million-position-in-staar-surgical-company-staa-2026-08-16/
Staar Surgical Co (STAA) Shares Surge 3.4% -- What GF Score of 80 Tells Investors
August 14, 2026  |  gurufocus.comhttps://www.gurufocus.com/news/9035959/staar-surgical-co-staa-shares-surge-34-what-gf-score-of-80-tells-investors
STAA Q2 deep dive: China demand and product expansion drive revenue growth amid market caution
August 14, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/staa-q2-deep-dive-china-demand-and-product-expansion-drive-revenue-growth-amid-market-caution/ar-AA2a6PVg
Clarification: Earns-Staar Surgical story
August 14, 2026  |  chron.comhttps://www.chron.com/business/article/staar-surgical-q2-earnings-snapshot-22385694.php
Clarification: Earns-Staar Surgical story
August 14, 2026  |  chron.comhttps://www.chron.com/business/article/staar-surgical-q2-earnings-snapshot-22385694.php
STAAR Surgical (NASDAQ:STAA) Shares Gap Down Following Analyst Downgrade
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/staar-surgical-nasdaqstaa-shares-gap-down-following-analyst-downgrade-2026-08-13/
STAAR Surgical (NASDAQ:STAA) Price Target Lowered to $37.00 at Wedbush
August 13, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/staar-surgical-nasdaqstaa-price-target-lowered-to-3700-at-wedbush-2026-08-13/
STAAR Surgical Reports Second Quarter 2026 Results
August 13, 2026  |  aol.comA

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bioventus stock logo

Bioventus NASDAQ:BVS

$13.84 +0.05 (+0.36%)
As of 08/28/2026 04:00 PM Eastern

Bioventus Inc. a medical device company, focuses on developing and commercializing clinically treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies comprise an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Orchestra BioMed stock logo

Orchestra BioMed NASDAQ:OBIO

$5.18 +0.07 (+1.37%)
As of 08/28/2026 04:00 PM Eastern

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$20.83 +0.23 (+1.12%)
As of 08/28/2026 04:00 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

STAAR Surgical stock logo

STAAR Surgical NASDAQ:STAA

$22.11 -0.28 (-1.25%)
As of 08/28/2026 04:00 PM Eastern

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas